Neurological Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Neuromodulation Devices, Detachable Coils, Liquid Embolics, and 8 more
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 648
- Published Date: 03/21/2023
- Type: MedSuite
Overall, the global neurological device market was valued at $9 billion in 2022. This is expected to increase over the forecast period at a CAGR of 6% to reach $13.5 billion.
The full report suite on the global neurological device market includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, neurovascular thrombectomy management, neuromodulation devices, intrathecal pumps and stereotactic devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL NEUROLOGICAL DEVICE MARKET INSIGHTS
Neuromodulation devices comprise the largest segment for neurological devices, divided between several competitors in the spinal cord stimulation and deep brain stimulation space. Most other segments within the global neurological device market, including vagus nerve stimulation and gastric electric stimulation, remain monopolized market segments at the time of publication. The sacral nerve stimulation market has seen recent product launches from new entrants, such as Axonics.
GLOBAL NEUROLOGICAL DEVICE MARKET SHARE INSIGHTS
Out of 50+ neurological device companies analyzed, the global market share is dominated by three key players – Medtronic, Boston Scientific, Stryker. 
Medtronic has maintained its leading position in the global neurological device market, but competitors have broken its monopoly on several markets and taken notable shares. Axonics’ entrance into the sacral nerve stimulator market has impacted Medtronic’s share, while innovations by Boston Scientific and Abbott have allowed these companies to gain sizeable shares of the deep brain stimulation (DBS) market. Medtronic remained a leader in the majority of markets presented in this report, including but not limited to liquid embolics, neurovascular stents, neurovascular thrombectomy management and intrathecal pump.
MARKET SEGMENTATION SUMMARY
While this report suite on the global neurological device market contains all applicable neurological device market data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the neurological market research that you need. You can view these separate reports and segmentation here:
- Global Cerebrospinal Fluid Management Market – MedCore – Includes:
- CSF shunt and CSF drainage shunt segments.
- Global Detachable Coil Market – MedCore – Includes:
- Bare platinum detachable coils and coated coils.
- Global Liquid Embolic Market – MedCore – Includes:
- Liquid embolics.
- Global Neurovascular Guidewire Market – MedCore – Includes:
- Neurovascular guidewires.
- Global Neurovascular Catheter Market – MedCore – Includes:
- Over-the-wire microcatheters, flow-directed microcatheters and neurovascular guiding catheters.
- Global Neurovascular Stent Market – MedCore – Includes:
- Traditional neurovascular stents, flow diversion stents and intrasaccular stents.
- Global Aneurysm Clip Market – MedCore – Includes:
- Titanium aneurysm clips and cobalt alloy aneurysm clips.
- Global Neurovascular Thrombus Management Market – MedCore – Includes:
- Stent retrievers and aspiration catheters.
- Global Neuromodulation Device Market – MedCore – Includes:
- Spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation.
- Global Intrathecal Pump Market – MedCore – Includes:
- Intrathecal pumps.
- Global Stereotactic Device Market – MedCore – Includes:
- Stereotactic devices.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Brazil) Western Europe (Benelux, France, Germany, Italy, Nordics, Spain, United Kingdom) Central & Eastern Europe (Poland, Russia) Asia Pacific (Australia, China, India, Japan, South Korea) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| Global Neurological Device Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedures Included |
| Markets Included |
| Regions Included |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE global Neurological Device Market |
| 2.1 Introduction |
| 2.2 Regional Profiles |
| 2.3 Analysis By Market Segment |
| 2.3.1 Worst Case Scenario |
| 2.3.2 Base Case Scenario |
| 2.3.3 Best Case Scenario |
| Disease Overview |
| 3.1 Basic Anatomy |
| 3.2 Disease Pathology and Disorders |
| 3.2.1 Introduction |
| 3.2.2 General Diagnostics and Neurosurgery |
| 3.2.3 Tumor and Brain Cancer |
| 3.2.4 Brain Arteriovenous Malformations |
| 3.2.5 Ischemic Stroke |
| 3.2.6 Brain Aneurysm |
| 3.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure |
| 3.2.7.1 Hydrocephalus and Intracranial Pressure Disorder |
| 3.2.7.2 Cerebral Edema |
| 3.2.8 Indication for Neuromodulation |
| 3.2.9 Traumatic Brain injury |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Cerebrospinal Fluid Management |
| 4.2.2 Detachable Coils |
| 4.2.3 Liquid Embolics |
| 4.2.4 Neurovascular Guidewires |
| 4.2.5 Neurovascular Catheters |
| 4.2.6 Neurovascular Stents |
| 4.2.7 Aneurysm Clip |
| 4.2.8 Neurovascular Thrombus Management |
| 4.2.9 Neuromodulation Devices |
| 4.2.9.1 Introduction |
| 4.2.9.2 Spinal Cord Stimulators |
| 4.2.9.3 Vagus Nerve Stimulators |
| 4.2.9.4 Deep Brain Stimulators |
| 4.2.9.5 Gastric Electric Stimulators |
| 4.2.9.6 Sacral Nerve Stimulators |
| 4.2.10 Intrathecal Pumps |
| 4.2.11 Stereotactic Devices |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Cerebrospinal Fluid Management |
| 4.3.2 Detachable Coils |
| 4.3.3 Neurovascular Catheters |
| 4.3.4 Neurovascular Stent |
| 4.3.5 Neuromodulation Devices |
| 4.3.6 Stereotactic Devices |
| 4.3.7 Intrathecal Pumps |
| 4.3.8 Mechanical Thrombectomy |
| 4.4 Clinical Trials |
| 4.4.1 Cerebrospinal Fluid Management |
| 4.4.2 Detachable Coils |
| 4.4.3 Liquid Embolics |
| 4.4.4 Neurovascular Catheters |
| 4.4.5 Neurovascular Guidewires |
| 4.4.6 Neurovascular Stent |
| 4.4.7 Neuromodulation Devices |
| 4.4.8 Stereotactic Devices |
| 4.4.9 Aneurysm Clip |
| 4.4.10 Mechanical Thrombectomy |
| Global Neurological Device Market Overview |
| 5.1 Introduction |
| 5.1.1 Cerebrospinal Fluid Management |
| 5.1.2 Interventional Neuroradiology |
| 5.1.3 Neuromodulation |
| 5.1.4 Neurosurgery |
| 5.1.5 Neurovascular Thrombus Management |
| 5.2 Market Overview & Trend Analysis |
| 5.2.1 By Segment |
| 5.2.2 By Region |
| 5.3 Drivers and Limiters |
| 5.3.1 Market Drivers |
| 5.3.1.1 Cerebrospinal Fluid Management |
| 5.3.1.2 Interventional Neuroradiology |
| 5.3.1.3 Neuromodulation |
| 5.3.1.4 Neurosurgery |
| 5.3.1.5 Neurovascular Thrombus Management |
| 5.3.2 Market Limiters |
| 5.3.2.1 Cerebrospinal Fluid Management |
| 5.3.2.2 Interventional Neuroradiology |
| 5.3.2.3 Neuromodulation |
| 5.3.2.4 Neurosurgery |
| 5.3.2.5 Neurovascular Thrombus Management |
| 5.4 Competitive Market Share Analysis |
| 5.5 Mergers and Acquisitions |
| 5.6 Company Profiles |
| 5.6.1 Abbott |
| 5.6.2 B. Braun |
| 5.6.3 Boston Scientific |
| 5.6.4 Cerenovus |
| 5.6.5 Integra LifeSciences |
| 5.6.5.1 Codman & Shurtleff |
| 5.6.6 LivaNova |
| 5.6.7 Medtronic |
| 5.6.8 MicroVention |
| 5.6.9 Mizuho |
| 5.6.10 Stryker |
| 5.7 SWOT Analysis |
| 5.7.1 Abbott |
| 5.7.2 B. Braun |
| 5.7.3 Boston Scientific |
| 5.7.4 Integra LifeSciences |
| 5.7.5 LivaNova |
| 5.7.6 Medtronic |
| 5.7.7 MicroVention |
| 5.7.8 Mizuho |
| 5.7.9 Stryker |
| Cerebrospinal Fluid Management Market |
| 6.1 Executive Summary |
| 6.1.1 Global Cerebrospinal Fluid Management Market Overview |
| 6.1.2 Competitive Analysis |
| 6.1.3 Markets Included |
| 6.1.4 Regions Included |
| 6.2 Introduction |
| 6.3 Procedure Numbers |
| 6.3.1 Total Cerebrospinal Fluid Shunting Procedures |
| 6.4 Market Overview |
| 6.4.1 By Segment |
| 6.4.2 By Region |
| 6.5 Market Analysis and Forecast |
| 6.5.1 Total Cerebrospinal Fluid Management Market |
| 6.5.2 Cerebrospinal Fluid Shunt Market |
| 6.5.3 Cerebrospinal Fluid Drainage System Market |
| 6.6 Drivers and Limiters |
| 6.6.1 Market Drivers |
| 6.6.2 Market Limiters |
| 6.7 Competitive Market Share Analysis |
| Detachable Coil Market |
| 7.1 Executive Summary |
| 7.1.1 Global Detachable Coil Market Overview |
| 7.1.2 Competitive Analysis |
| 7.1.3 Markets Included |
| 7.1.4 Regions Included |
| 7.2 Introduction |
| 7.3 Procedure Numbers |
| 7.4 Market Overview |
| 7.4.1 By Segment |
| 7.4.2 By Region |
| 7.5 Market Analysis and Forecast |
| 7.5.1 Total Detachable Coil Market |
| 7.5.2 Bare Platinum Detachable Coil Market |
| 7.5.3 Coated Detachable Coil Market |
| 7.6 Drivers and Limiters |
| 7.6.1 Market Drivers |
| 7.6.2 Market Limiters |
| 7.7 Competitive Market Share Analysis |
| Liquid Embolic Market |
| 8.1 Executive Summary |
| 8.1.1 Global Liquid Embolic Market Overview |
| 8.1.2 Competitive Analysis |
| 8.1.3 Regions Included |
| 8.2 Introduction |
| 8.3 Procedure Numbers |
| 8.4 Market Analysis and Forecast |
| 8.5 Drivers and Limiters |
| 8.5.1 Market Drivers |
| 8.5.2 Market Limiters |
| 8.6 Competitive Market Share Analysis |
| Neurovascular Guidewire Market |
| 9.1 Executive Summary |
| 9.1.1 Global Neurovascular Guidewire Market Overview |
| 9.1.2 Competitive Analysis |
| 9.1.3 Regions Included |
| 9.2 Introduction |
| 9.3 Market Analysis and Forecast |
| 9.4 Drivers and Limiters |
| 9.4.1 Market Drivers |
| 9.4.2 Market Limiters |
| 9.5 Competitive Market Share Analysis |
| Neurovascular Catheter Market |
| 10.1 Executive Summary |
| 10.1.1 Global Neurovascular Catheter Market Overview |
| 10.1.2 Competitive Analysis |
| 10.1.3 Regions Included |
| 10.2 Introduction |
| 10.3 Market Overview |
| 10.3.1 By Segment |
| 10.3.2 By Region |
| 10.4 Market Analysis and Forecast |
| 10.4.1 Total Neurovascular Catheter Market |
| 10.4.2 Over-the-Wire Microcatheter Market |
| 10.4.3 Flow-Directed Microcatheter Market |
| 10.4.4 Neurovascular Guiding Catheter Market |
| 10.5 Drivers and Limiters |
| 10.5.1 Market Drivers |
| 10.5.2 Market Limiters |
| 10.6 Competitive Market Share Analysis |
| NEUROVASCULAR STENT Market |
| 11.1 Executive Summary |
| 11.1.1 Global Neurovascular Stent Market Overview |
| 11.1.2 Competitive Analysis |
| 11.1.3 Markets Included |
| 11.1.4 Regions Included |
| 11.2 Introduction |
| 11.3 Procedure Numbers |
| 11.3.1 Total Neurovascular Stent Procedures |
| 11.4 Market Overview |
| 11.4.1 By Segment |
| 11.4.2 By Region |
| 11.5 Market Analysis and Forecast |
| 11.5.1 Total Neurovascular Stent Market |
| 11.5.2 Traditional Neurovascular Stent Market |
| 11.5.3 Flow Diversion Stent Market |
| 11.5.4 Intrasaccular Stent Market |
| 11.6 Drivers and Limiters |
| 11.6.1 Market Drivers |
| 11.6.2 Market Limiters |
| 11.7 Competitive Market Share Analysis |
| Aneurysm Clip Market |
| 12.1 Executive Summary |
| 12.1.1 Global Aneurysm Clip Market Overview |
| 12.1.2 Competitive Analysis |
| 12.1.3 Markets Included |
| 12.1.4 Regions Included |
| 12.2 Introduction |
| 12.3 Procedure Numbers |
| 12.4 Market Overview |
| 12.4.1 By Segment |
| 12.4.2 By Region |
| 12.5 Market Analysis and Forecast |
| 12.5.1 Total Aneurysm Clip Market |
| 12.5.2 Titanium Aneurysm Clip Market |
| 12.5.3 Cobalt Chromium Aneurysm Clip Market |
| 12.6 Drivers and Limiters |
| 12.6.1 Market Drivers |
| 12.6.2 Market Limiters |
| 12.7 Competitive Market Share Analysis |
| Neurovascular thrombus Management Market |
| 13.1 Executive Summary |
| 13.1.1 Global Neurovascular Thrombus Management Market Overview |
| 13.1.2 Competitive Analysis |
| 13.1.3 Markets Included |
| 13.1.4 Regions Included |
| 13.2 Introduction |
| 13.3 Procedure Numbers |
| 13.4 Market Overview |
| 13.4.1 By Segment |
| 13.4.2 By Region |
| 13.5 Market Analysis and Forecast |
| 13.5.1 Total Neurovascular Thrombus Management Market |
| 13.5.2 Stent Retriever Market |
| 13.5.3 Aspiration Catheter Market |
| 13.6 Drivers and Limiters |
| 13.6.1 Market Drivers |
| 13.6.2 Market Limiters |
| 13.7 Competitive Market Share Analysis |
| Neuromodulation Device Market |
| 14.1 Executive Summary |
| 14.1.1 Global Neuromodulation Device Market Overview |
| 14.1.2 Competitive Analysis |
| 14.1.3 Markets Included |
| 14.1.4 Regions Included |
| 14.2 Introduction |
| 14.2.1 Spinal Cord Stimulation |
| 14.2.2 Deep Brain Stimulation |
| 14.2.3 Sacral Nerve Stimulation |
| 14.2.4 Vagus Nerve Stimulation |
| 14.2.5 Gastric Electric Stimulation |
| 14.3 Procedure Numbers |
| 14.3.1 Total Neuromodulation Procedures |
| 14.3.2 Spinal Cord Stimulation Procedures |
| 14.3.3 Deep Brain Stimulation Procedures |
| 14.3.4 Sacral Nerve Stimulation Procedures |
| 14.3.5 Vagus Nerve Stimulation Procedures |
| 14.3.6 Gastric Electric Stimulation Procedures |
| 14.4 Market Overview |
| 14.4.1 By Segment |
| 14.4.2 By Region |
| 14.5 Market Analysis and Forecast |
| 14.5.1 Total Neuromodulation Device Market |
| 14.5.2 Spinal Cord Stimulation Market |
| 14.5.3 Deep Brain Stimulation Market |
| 14.5.4 Sacral Nerve Stimulation Market |
| 14.5.5 Vagus Nerve Stimulation Market |
| 14.5.6 Gastric Electric Stimulation Market |
| 14.6 Drivers and Limiters |
| 14.6.1 Market Drivers |
| 14.6.2 Market Limiters |
| 14.7 Competitive Market Share Analysis |
| Intrathecal Pump Market |
| 15.1 Executive Summary |
| 15.1.1 Global Intrathecal Pump Market Overview |
| 15.1.2 Competitive Analysis |
| 15.1.3 Regions Included |
| 15.2 Introduction |
| 15.3 Procedure Numbers |
| 15.4 Market Analysis and Forecast |
| 15.5 Drivers and Limiters |
| 15.5.1 Market Drivers |
| 15.5.2 Market Limiters |
| 15.6 Competitive Market Share Analysis |
| Stereotactic Device Market |
| 16.1 Executive Summary |
| 16.1.1 Global Stereotactic Market Overview |
| 16.1.2 Competitive Analysis |
| 16.1.3 Regions Included |
| 16.2 Introduction |
| 16.3 Market Analysis and Forecast |
| 16.4 Drivers and Limiters |
| 16.4.1 Market Drivers |
| 16.4.2 Market Limiters |
| 16.5 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · Abbott | · Imperative Care |
| · Acandis | · Inomed |
| · Accuracy | · Insera Therapeutics |
| · Adeor Medical | · Integra LifeSciences |
| · Aesculap | · IntraPace |
| · ANT Neuro | · IRRAS |
| · Asahi Intecc | · Kaneka |
| · Axonics | · LivaNova |
| · Balt | · MAG & More |
| · Bioventus | · Magstim |
| · Biosense Webster | · MagVenture |
| · Boston Scientific | · Medtronic |
| · Brainlab | · Meril |
| · BrainsWay | · MHT |
| · BTG | · MicroPort |
| · Cerenovus | · MicroVention |
| · Cerus Endovascular | · Misonix |
| · Cirtec Medical | · MIVI Neuroscience |
| · Cordis | · Mizuho |
| · Dewimed | · MRC Systems |
| · Deymed Diagnostic | · Neuromedex |
| · Dispomedica | · Neuronetics |
| · Elekta | · NeuroPace |
| · Embolx | · Neurosoft |
| · FHC | · Nevro |
| · Flowonix | · Nexstim |
| · Penumbra | · Soring |
| · Peter Lazic | · Spiegelberg |
| · Phenox | · Stryker |
| · Rapid Medical | · Teleflex |
| · Reshape Lifesciences | · Tokai Medical Products |
| · SAI Infusion Technologies | · Tricumed |
| · Scientia Vascular | · Varian |
| · Sophysa |
List of Charts
| Chart 1‑1: Neurological Device Market by Segment, Global, 2022 – 2029 |
| Chart 1‑2: Neurological Device Procedures, Global, 2022 |
| Chart 2‑1: Multi-Scenario Neurological Device Market Forecast, Global, 2019 – 2029 (US$M) |
| Chart 5‑1: Neurological Device Market by Segment, Global, 2019 – 2029 |
| Chart 5‑2: Neurological Device Market by Region, Global, 2019 – 2029 |
| Chart 5‑3: Leading Competitors, Neurological Device Market, Global, 2022 |
| Chart 6‑1: Cerebrospinal Fluid Management Market, Global, 2022 & 2029 |
| Chart 6‑2: Cerebrospinal Fluid Management Procedures, Global, 2022 |
| Chart 6‑3: Cerebrospinal Fluid Shunting Procedures by Region, Global, 2019 – 2029 |
| Chart 6‑4: Cerebrospinal Fluid Management Market by Segment, Global, 2019 – 2029 |
| Chart 6‑5: Cerebrospinal Fluid Management Market by Region, Global, 2019 – 2029 |
| Chart 6‑6: Leading Competitors, Cerebrospinal Fluid Management Market, Global, 2022 |
| Chart 7‑1: Detachable Coil Market, Global, 2022 & 2029 |
| Chart 7‑2: Detachable Coil Procedures, Global, 2022 |
| Chart 7‑3: Detachable Coil Procedures by Region, Global, 2019 – 2029 |
| Chart 7‑4: Detachable Coil Market by Segment, Global, 2019 – 2029 |
| Chart 7‑5: Detachable Coil Market by Region, Global, 2019 – 2029 |
| Chart 7‑6: Leading Competitors, Detachable Coil Market, Global, 2022 |
| Chart 8‑1: Liquid Embolic Market, Global, 2022 & 2029 |
| Chart 8‑2: Liquid Embolic Procedures, Global, 2022 |
| Chart 8‑3: Liquid Embolic Procedures by Region, Global, 2019 – 2029 |
| Chart 8‑4: Liquid Embolic Market, Global, 2019 – 2029 |
| Chart 8‑5: Leading Competitors, Liquid Embolic Market, Global, 2022 |
| Chart 9‑1: Neurovascular Guidewire Market, Global, 2022 & 2029 |
| Chart 9‑2: Neurovascular Guidewire Units Sold, Global, 2022 |
| Chart 9‑3: Neurovascular Guidewire Market, Global, 2019 – 2029 |
| Chart 9‑4: Leading Competitors, Neurovascular Guidewire Market, Global, 2022 |
| Chart 10‑1: Neurovascular Catheter Market, Global, 2022 & 2029 |
| Chart 10‑2: Neurovascular Catheter Units Sold, Global, 2022 |
| Chart 10‑3: Neurovascular Catheter Market by Segment, Global, 2019 – 2029 |
| Chart 10‑4: Neurovascular Catheter Market by Region, Global, 2019 – 2029 |
| Chart 10‑5: Leading Competitors, Neurovascular Catheter Market, Global, 2022 |
| Chart 11‑1: Neurovascular Stent Market, Global, 2022 & 2029 |
| Chart 11‑2: Neurovascular Stent Procedures, Global, 2022 |
| Chart 11‑3: Neurovascular Stent Procedures by Region, Global, 2019 – 2029 |
| Chart 11‑4: Neurovascular Stent Market by Segment, Global, 2019 – 2029 |
| Chart 11‑5: Neurovascular Stent Market by Region, Global, 2019 – 2029 |
| Chart 11‑6: Leading Competitors, Neurovascular Stent Market, Global, 2022 |
| Chart 12‑1: Aneurysm Clip Market, Global, 2022 & 2029 |
| Chart 12‑2: Aneurysm Treatment Procedures, Global, 2022 |
| Chart 12‑3: Total Aneurysm Treatment Procedures by Region, Global, 2019 – 2029 |
| Chart 12‑4: Aneurysm Clip Market by Region, Global, 2019 – 2029 |
| Chart 12‑5: Leading Competitors, Aneurysm Clip Market, Global, 2022 |
| Chart 13‑1: Neurovascular Thrombus Management Market, Global, 2022 & 2029 |
| Chart 13‑2: Neurovascular Thrombus Management Procedures, Global, 2022 |
| Chart 13‑3: Neurovascular Thrombus Management Procedures by Region, Global, 2019 – 2029 |
| Chart 13‑4: Neurovascular Thrombus Management Market by Region, Global, 2019 – 2029 |
| Chart 13‑5: Leading Competitors, Neurovascular Thrombus Management Market, Global, 2022 |
| Chart 14‑1: Neuromodulation Device Market, Global, 2022 & 2029 |
| Chart 14‑2: Neuromodulation Device Procedures, Global, 2022 |
| Chart 14‑3: Total Neuromodulation Procedures by Region, Global, 2019 – 2029 |
| Chart 14‑4: Neuromodulation Device Market by Region, Global, 2019 – 2029 |
| Chart 14‑5: Leading Competitors, Neuromodulation Device Market, Global, 2022 |
| Chart 15‑1: Intrathecal Pump Market, Global, 2022 & 2029 |
| Chart 15‑2: Intrathecal Pump Procedures, Global, 2022 |
| Chart 15‑3: Intrathecal Pump Procedures by Region, Global, 2019 – 2029 |
| Chart 15‑4: Intrathecal Pump Market, Global, 2019 – 2029 |
| Chart 15‑5: Leading Competitors, Intrathecal Pump Market, Global, 2022 |
| Chart 16‑1: Stereotactic Device Market, Global, 2022 & 2029 |
| Chart 16‑2: Stereotactic Procedures, Global, 2022 |
| Chart 16‑3: Stereotactic Market, Global, 2019 – 2029 |
| Chart 16‑4: Leading Competitors, Stereotactic Market, Global, 2022 |
List of Figures
| Figure 1‑1: Neurological Device Market Share Ranking by Segment, Global, 2022 (1 of 2) |
| Figure 1‑2: Neurological Device Market Share Ranking by Segment, Global, 2022 (2 of 2) |
| Figure 1‑3: Companies Researched in This Report (1 of 2) |
| Figure 1‑4: Companies Researched in This Report (2 of 2) |
| Figure 1‑5: Factors Impacting the Neurological Device Market by Segment, Global (1 of 2) |
| Figure 1‑6: Factors Impacting the Neurological Device Market by Segment, Global (2 of 2) |
| Figure 1‑7: Recent Events in the Neurological Device Market, Global, 2019 – 2023 (1 of 2) |
| Figure 1‑8: Recent Events in the Neurological Device Market, Global, 2019 – 2023 (2 of 2) |
| Figure 1‑9: Global Neurological Device Procedures Covered |
| Figure 1‑10: Global Neurological Device Markets Covered |
| Figure 1‑11: Neurological Device Regions Covered, Global (1 of 2) |
| Figure 1‑12: Neurological Device Regions Covered, Global (2 of 2) |
| Figure 1‑13: Version History |
| Figure 2‑1: Neurological Device Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑2: Neurological Device Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑3: Neurological Device Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑4: Neurological Device Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑5: Neurological Device Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑6: Neurological Device Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
| Figure 3‑1: Neurology Disease Overview |
| Figure 4‑1: Shunt Types |
| Figure 4‑2: Cerebrospinal Fluid Management by Company |
| Figure 4‑3: Detachable Coils by Company |
| Figure 4‑4: Liquid Embolics by Company |
| Figure 4‑5: Neurovascular Guidewires by Company |
| Figure 4‑6: Neurovascular Catheters by Company |
| Figure 4‑7: Neurovascular Stent by Company |
| Figure 4‑8: Aneurysm Clip Devices by Company |
| Figure 4‑9: Neurovascular Thrombus Management Devices by Company |
| Figure 4‑10: Neuromodulation Devices by Company |
| Figure 4‑11: Intrathecal Pumps Devices by Company |
| Figure 4‑12: Stereotactic Devices by Company |
| Figure 4‑13: Class 2 Device Recall Natus EDS3 CSF External Drainage System |
| Figure 4‑14: Class 2 Device Recall Medtronic PS Medical CSFFlow Control Valves |
| Figure 4‑15: Class 2 Device Recall MicroVention Terumo Microplex 10, Helical 10 Soft |
| Figure 4‑16: Class 2 Device Recall MicroVention Terumo HydroFrame 10 and 18 |
| Figure 4‑17: Class 2 Device Recall MicroVention Terumo Microplex 10, Compass 10 |
| Figure 4‑18: Class 2 Device Recall MicroVention Terumo HydroSoft 10, HydroSoft 3D |
| Figure 4‑19: Class 2 Device Recall GALAXY G3 Mini Microcoil Delivery System |
| Figure 4‑20: Class 2 Device Recall C315HIS Delivery Catheter |
| Figure 4‑21: Class 2 Device Recall MIVI Super 90 Guide Catheters |
| Figure 4‑22:Class 2 Device Recall MAMBA Flex 135 Microcatheter |
| Figure 4‑23: Class 2 Device Recall Intracranial Neurovascular Stent |
| Figure 4‑24: Class 2 Device Recall Medtronic Wireless Recharger |
| Figure 4‑25: Class 2 Device Recall Model B352000 Percept PC BrainSense Implantable Neurostimulator |
| Figure 4‑26: Class 2 Device Recall A610 |
| Figure 4‑27: Class 2 Device Recall Percept PC Implantable Neurostimulator (INS) |
| Figure 4‑28: Class 2 Device Recall Stealth Autoguide Tracker, Model: 28248 |
| Figure 4‑29:Class 2 Device Recall Medtronic |
| Figure 4‑30: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System |
| Figure 4‑31:Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑32: Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑33:Class 2 Device Recall ROSA Brain 3.0 Application Brain and ROSA One 3.1 |
| Figure 4‑34: Class 2 Device Recall Prometra Programmable Pump System |
| Figure 4‑35: Class 2 Device Recall Medtronic Synchromed II Implantable Drug Infusion Pump |
| Figure 4‑36: Class 2 Device Recall AXS Vecta 71 , Vecta 74 Aspiration Catheter |
| Figure 4‑37: Class 1 Device Recall MINDFRAME CAPTURE(TM) LP Revascularization Device |
| Figure 4‑38: Class 2 Device Recall Trevo XP ProVue System |
| Figure 4‑39: The Effect of Lumbar CSF Drainage on the Neurologic Outcome Improvement in OHCA Underwent TTM |
| Figure 4‑40: Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial (OPEN-UP) |
| Figure 4‑41: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension. (HYDROPTIC) |
| Figure 4‑42: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
| Figure 4‑43: Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms |
| Figure 4‑44: Transcatheter Leak Closure with Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures (TREASURE) |
| Figure 4‑45: Middle Meningeal Artery Embolization with Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma |
| Figure 4‑46: Treatment of Cerebral Arteriovenous Malformations with SQUID Liquid Embolic Agent - The CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study |
| Figure 4‑47: Squid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding Syndrome (SQUIDperi Study) (SQUIDperi) |
| Figure 4‑48: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations |
| Figure 4‑49: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
| Figure 4‑50: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion |
| Figure 4‑51: Inflammatory and Infectious Diseases of the Nervous System |
| Figure 4‑52: Safety and Utility Profile of the Asahi Chikai Black 18 neurovascular guidewire in Large Vessel Occlusive Stroke: SURE 18 Registry |
| Figure 4‑53: Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for Intracranial Aneurysm Treatment - Post Market Clinical Follow-up |
| Figure 4‑54: Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System |
| Figure 4‑55: MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization (PARADIGM-EXT) |
| Figure 4‑56: The Motor Network in Essential Tremor: Mechanisms of Therapy |
| Figure 4‑57: Wearable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease (WAVE-AD) |
| Figure 4‑58: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents Visiting the Emergency Department |
| Figure 4‑59: Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases |
| Figure 4‑60: Cyberknife Radiosurgery for Patients with Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity |
| Figure 4‑61: Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases |
| Figure 4‑62: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping |
| Figure 4‑63: Regional Strategy for Transfer for Mechanical Thrombectomy (START) |
| Figure 4‑64: Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion (DISCOUNT) |
| Figure 5‑1: Neurological Device Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) |
| Figure 5‑2: Neurological Device Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) |
| Figure 5‑3: Neurological Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 5‑4: Leading Competitors, Neurological Device Market by Segment, Global, 2022 (1 of 2) |
| Figure 5‑5: Leading Competitors, Neurological Device Market by Segment, Global, 2022 (2 of 2) |
| Figure 5‑6: SWOT Analysis, Abbott |
| Figure 5‑7: SWOT Analysis, B. Braun |
| Figure 5‑8 SWOT Analysis, Boston Scientific |
| Figure 5‑9: SWOT Analysis, Integra LifeSciences |
| Figure 5‑10: SWOT Analysis, LivaNova |
| Figure 5‑11: SWOT Analysis, Medtronic |
| Figure 5‑12: SWOT Analysis, MicroVention |
| Figure 5‑13: SWOT Analysis, Mizuho |
| Figure 5‑14: SWOT Analysis, Stryker |
| Figure 6‑1: Cerebrospinal Fluid Management Markets Covered |
| Figure 6‑2: Cerebrospinal Fluid Management Regions Covered, Global (1 of 2) |
| Figure 6‑3: Cerebrospinal Fluid Management Regions Covered, Global (2 of 2) |
| Figure 6‑4: Cerebrospinal Fluid Shunting Procedures by Region, Global, 2019 – 2029 |
| Figure 6‑5: Cerebrospinal Fluid Shunting Procedures by Country, North America, 2019 – 2029 |
| Figure 6‑6: Cerebrospinal Fluid Shunting Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 6‑7: Cerebrospinal Fluid Shunting Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 6‑8: Cerebrospinal Fluid Shunting Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 6‑9: Cerebrospinal Fluid Shunting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 6‑10: Cerebrospinal Fluid Shunting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 6‑11: Cerebrospinal Fluid Shunting Procedures by Country, Middle East, 2019 – 2029 |
| Figure 6‑12: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 6‑13: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 6‑14: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 6‑15: Cerebrospinal Fluid Shunting Procedures by Country, Africa, 2019 – 2029 |
| Figure 6‑16: Cerebrospinal Fluid Management Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 6‑17: Cerebrospinal Fluid Management Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 6‑18: Cerebrospinal Fluid Management Market, Global, 2019 – 2029 |
| Figure 6‑19: Units Sold by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 |
| Figure 6‑20: Average Selling Price by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 (US$) |
| Figure 6‑21: Market Value by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑22: Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 |
| Figure 6‑23: Units Sold by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 |
| Figure 6‑24: Average Selling Price by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 (US$) |
| Figure 6‑25: Market Value by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑26: Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 |
| Figure 6‑27: Units Sold by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 |
| Figure 6‑28: Average Selling Price by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 (US$) |
| Figure 6‑29: Market Value by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑30: Leading Competitors, Cerebrospinal Fluid Management Market, Global, 2022 |
| Figure 7‑1: Detachable Coil Markets Covered |
| Figure 7‑2: Detachable Coil Regions Covered, Global (1 of 2) |
| Figure 7‑3: Detachable Coil Regions Covered, Global (2 of 2) |
| Figure 7‑4: Total Detachable Coil Procedures, Global, 2019 – 2029 |
| Figure 7‑5: Detachable Coil Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑6: Detachable Coil Procedures by Country, North America, 2019 – 2029 |
| Figure 7‑7: Detachable Coil Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 7‑8: Detachable Coil Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 7‑9: Detachable Coil Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 7‑10: Detachable Coil Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 7‑11: Detachable Coil Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 7‑12: Detachable Coil Procedures by Country, Middle East, 2019 – 2029 |
| Figure 7‑13: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 7‑14: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 7‑15: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 7‑16: Detachable Coil Procedures by Country, Africa, 2019 – 2029 |
| Figure 7‑17: Detachable Coil Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 7‑18: Detachable Coil Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 7‑19: Total Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑20: Units Sold by Region, Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑21: Average Selling Price by Region, Detachable Coil Market, Global, 2019 – 2029 (US$) |
| Figure 7‑22: Market Value by Region, Detachable Coil Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑23: Bare Platinum Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑24: Units Sold by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑25: Average Selling Price by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 (US$) |
| Figure 7‑26: Market Value by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑27: Coated Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑28: Units Sold by Region, Coated Detachable Coil Market, Global, 2019 – 2029 |
| Figure 7‑29: Average Selling Price by Region, Coated Detachable Coil Market, Global, 2019 – 2029 (US$) |
| Figure 7‑30: Market Value by Region, Coated Detachable Coil Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑31: Leading Competitors, Detachable Coil Market, Global, 2022 |
| Figure 8‑1: Liquid Embolic Regions Covered, Global (1 of 2) |
| Figure 8‑2: Liquid Embolic Regions Covered, Global (2 of 2) |
| Figure 8‑3: Total Liquid Embolic Procedures, Global, 2019 – 2029 |
| Figure 8‑4: Liquid Embolic Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑5: Liquid Embolic Procedures by Country, North America, 2019 – 2029 |
| Figure 8‑6: Liquid Embolic Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 8‑7: Liquid Embolic Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 8‑8: Liquid Embolic Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 8‑9: Liquid Embolic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 8‑10: Liquid Embolic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 8‑11: Liquid Embolic Procedures by Country, Middle East, 2019 – 2029 |
| Figure 8‑12: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 8‑13: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 8‑14: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 8‑15: Liquid Embolic Procedures by Country, Africa, 2019 – 2029 |
| Figure 8‑16: Liquid Embolic Market, Global, 2019 – 2029 |
| Figure 8‑17: Units Sold by Region, Liquid Embolic Market, Global, 2019 – 2029 |
| Figure 8‑18: Average Selling Price by Region, Liquid Embolic Market, Global, 2019 – 2029 (US$) |
| Figure 8‑19: Market Value by Region, Liquid Embolic Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑20: Leading Competitors, Liquid Embolic Market, Global, 2022 |
| Figure 9‑1: Neurovascular Guidewire Regions Covered, Global (1 of 2) |
| Figure 9‑2: Neurovascular Guidewire Regions Covered, Global (2 of 2) |
| Figure 9‑3: Neurovascular Guidewire Market, Global, 2019 – 2029 |
| Figure 9‑4: Units Sold by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 |
| Figure 9‑5: Average Selling Price by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 (US$) |
| Figure 9‑6: Market Value by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑7: Leading Competitors, Neurovascular Guidewire Market, Global, 2022 |
| Figure 10‑1: Neurovascular Catheter Regions Covered, Global (1 of 2) |
| Figure 10‑2: Neurovascular Catheter Regions Covered, Global (2 of 2) |
| Figure 10‑3: Neurovascular Catheter Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 10‑4: Neurovascular Catheter Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 10‑5: Neurovascular Catheter Market, Global, 2019 – 2029 |
| Figure 10‑6: Units Sold by Region, Neurovascular Catheter Market, Global, 2019 – 2029 |
| Figure 10‑7: Average Selling Price by Region, Neurovascular Catheter Market, Global, 2019 – 2029 (US$) |
| Figure 10‑8: Market Value by Region, Neurovascular Catheter Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑9: Over-the-Wire Microcatheter Market, Global, 2019 – 2029 |
| Figure 10‑10: Units Sold by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 |
| Figure 10‑11: Average Selling Price by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 (US$) |
| Figure 10‑12: Market Value by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑13: Flow-Directed Microcatheter Market, Global, 2019 – 2029 |
| Figure 10‑14: Units Sold by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 |
| Figure 10‑15: Average Selling Price by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 (US$) |
| Figure 10‑16: Market Value by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑17: Neurovascular Guiding Catheter Market, Global, 2019 – 2029 |
| Figure 10‑18: Units Sold by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 |
| Figure 10‑19: Average Selling Price by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 (US$) |
| Figure 10‑20: Market Value by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 (US$M) |
| Figure 10‑21: Leading Competitors, Neurovascular Catheter Market, Global, 2022 |
| Figure 11‑1: Neurovascular Stent Markets Covered |
| Figure 11‑2: Neurovascular Stent Regions Covered, Global (1 of 2) |
| Figure 11‑3: Neurovascular Stent Regions Covered, Global (2 of 2) |
| Figure 11‑4: Neurovascular Stent Procedures by Region, Global, 2019 – 2029 |
| Figure 11‑5: Neurovascular Stent Procedures by Country, North America, 2019 – 2029 |
| Figure 11‑6: Neurovascular Stent Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 11‑7: Neurovascular Stent Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 11‑8: Neurovascular Stent Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 11‑9: Neurovascular Stent Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 11‑10: Neurovascular Stent Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 11‑11: Neurovascular Stent Procedures by Country, Middle East, 2019 – 2029 |
| Figure 11‑12: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 11‑13: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 11‑14: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 11‑15: Neurovascular Stent Procedures by Country, Africa, 2019 – 2029 |
| Figure 11‑16: Neurovascular Stent Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 11‑17: Neurovascular Stent Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 11‑18: Neurovascular Stent Market, Global, 2019 – 2029 |
| Figure 11‑19: Units Sold by Region, Neurovascular Stent Market, Global, 2019 – 2029 |
| Figure 11‑20: Average Selling Price by Region, Neurovascular Stent Market, Global, 2019 – 2029 (US$) |
| Figure 11‑21: Market Value by Region, Neurovascular Stent Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑22: Traditional Neurovascular Stent Market, Global, 2019 – 2029 |
| Figure 11‑23: Units Sold by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 |
| Figure 11‑24: Average Selling Price by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 (US$) |
| Figure 11‑25: Market Value by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑26: Flow Diversion Stent Market, Global, 2019 – 2029 |
| Figure 11‑27: Units Sold by Region, Flow Diversion Stent Market, Global, 2019 – 2029 |
| Figure 11‑28: Average Selling Price by Region, Flow Diversion Stent Market, Global, 2019 – 2029 (US$) |
| Figure 11‑29: Market Value by Region, Flow Diversion Stent Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑30: Intrasaccular Stent Market, Global, 2019 – 2029 |
| Figure 11‑31: Units Sold by Region, Intrasaccular Stent Market, Global, 2019 – 2029 |
| Figure 11‑32: Average Selling Price by Region, Intrasaccular Stent Market, Global, 2019 – 2029 (US$) |
| Figure 11‑33: Market Value by Region, Intrasaccular Stent Market, Global, 2019 – 2029 (US$M) |
| Figure 11‑34: Leading Competitors, Neurovascular Stent Market, Global, 2022 |
| Figure 12‑1: Aneurysm Clip Markets Covered |
| Figure 12‑2: Aneurysm Clip Regions Covered, Global (1 of 2) |
| Figure 12‑3: Aneurysm Clip Regions Covered, Global (2 of 2) |
| Figure 12‑4: Total Aneurysm Treatment Procedures by Region, Global, 2019 – 2029 |
| Figure 12‑5: Total Aneurysm Treatment Procedures by Country, North America, 2019 – 2029 |
| Figure 12‑6: Total Aneurysm Treatment Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 12‑7: Total Aneurysm Treatment Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 12‑8: Total Aneurysm Treatment Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 12‑9: Total Aneurysm Treatment Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 12‑10: Total Aneurysm Treatment Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 12‑11: Total Aneurysm Treatment Procedures by Country, Middle East, 2019 – 2029 |
| Figure 12‑12: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 12‑13: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 12‑14: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 12‑15: Total Aneurysm Treatment Procedures by Country, Africa, 2019 – 2029 |
| Figure 12‑16: Aneurysm Clip Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 12‑17: Aneurysm Clip Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 12‑18: Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑19: Units Sold by Region, Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑20: Average Selling Price by Region, Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
| Figure 12‑21: Market Value by Region, Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑22: Titanium Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑23: Units Sold by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑24: Average Selling Price by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
| Figure 12‑25: Market Value by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑26: Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑27: Units Sold by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 |
| Figure 12‑28: Average Selling Price by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
| Figure 12‑29: Market Value by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
| Figure 12‑30: Leading Competitors, Aneurysm Clip Market, Global, 2022 |
| Figure 13‑1: Neurovascular Thrombus Management Markets Covered |
| Figure 13‑2: Neurovascular Thrombus Management Regions Covered, Global (1 of 2) |
| Figure 13‑3: Neurovascular Thrombus Management Regions Covered, Global (2 of 2) |
| Figure 13‑4: Neurovascular Thrombus Management Procedures by Segment, Global, 2019 – 2029 |
| Figure 13‑5: Neurovascular Thrombus Management Procedures by Region, Global, 2019 – 2029 |
| Figure 13‑6: Neurovascular Thrombus Management Procedures by Country, North America, 2019 – 2029 |
| Figure 13‑7: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 13‑8: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 13‑9: Neurovascular Thrombus Management Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 13‑10: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 13‑11: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 13‑12: Neurovascular Thrombus Management Procedures by Country, Middle East, 2019 – 2029 |
| Figure 13‑13: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 13‑14: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 13‑15: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 13‑16: Neurovascular Thrombus Management Procedures by Country, Africa, 2019 – 2029 |
| Figure 13‑17: Neurovascular Thrombus Management Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 13‑18: Neurovascular Thrombus Management Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 13‑19: Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
| Figure 13‑20: Units Sold by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
| Figure 13‑21: Average Selling Price by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$) |
| Figure 13‑22: Market Value by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑23: Stent Retriever Market, Global, 2019 – 2029 |
| Figure 13‑24: Units Sold by Region, Stent Retriever Market, Global, 2019 – 2029 |
| Figure 13‑25: Average Selling Price by Region, Stent Retriever Market, Global, 2019 – 2029 (US$) |
| Figure 13‑26: Market Value by Region, Stent Retriever Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑27: Aspiration Catheter Market, Global, 2019 – 2029 |
| Figure 13‑28: Units Sold by Region, Aspiration Catheter Market, Global, 2019 – 2029 |
| Figure 13‑29: Average Selling Price by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$) |
| Figure 13‑30: Market Value by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$M) |
| Figure 13‑31: Leading Competitors, Neurovascular Thrombus Management Market, Global, 2022 |
| Figure 14‑1: Neuromodulation Device Markets Covered |
| Figure 14‑2: Neuromodulation Device Regions Covered, Global (1 of 2) |
| Figure 14‑3: Neuromodulation Device Regions Covered, Global (2 of 2) |
| Figure 14‑4: Total Neuromodulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑5: Total Neuromodulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑6: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑7: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑8: Total Neuromodulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑9: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑10: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑11: Total Neuromodulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑12: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑13: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑14: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑15: Total Neuromodulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑16: Spinal Cord Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑17: Spinal Cord Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑18: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑19: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑20: Spinal Cord Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑21: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑22: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑23: Spinal Cord Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑24: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑25: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑26: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑27: Spinal Cord Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑28: Deep Brain Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑29: Deep Brain Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑30: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑31: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑32: Deep Brain Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑33: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑34: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑35: Deep Brain Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑36: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑37: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑38: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑39: Deep Brain Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑40: Sacral Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑41: Sacral Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑42: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑43: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑44: Sacral Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑45: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑46: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑47: Sacral Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑48: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑49: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑50: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑51: Sacral Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑52: Vagus Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑53: Vagus Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑54: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑55: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑56: Vagus Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑57: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑58: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑59: Vagus Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑60: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑61: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑62: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑63: Vagus Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑64: Gastric Electric Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑65: Neuromodulation Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 14‑66: Neuromodulation Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 14‑67: Neuromodulation Device Market, Global, 2019 – 2029 |
| Figure 14‑68: Units Sold by Region, Neuromodulation Device Market, Global, 2019 – 2029 |
| Figure 14‑69: Average Selling Price by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$) |
| Figure 14‑70: Market Value by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑71: Spinal Cord Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑72: Units Sold by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑73: Average Selling Price by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑74: Market Value by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑75: Deep Brain Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑76: Units Sold by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑77: Average Selling Price by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑78: Market Value by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑79: Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑80: Units Sold by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑81: Average Selling Price by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑82: Market Value by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑83: Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑84: Units Sold by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑85: Average Selling Price by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑86: Market Value by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑87: Gastric Electric Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑88: Units Sold by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑89: Average Selling Price by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑90: Market Value by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑91: Leading Competitors, Neuromodulation Device Market, Global, 2022 |
| Figure 15‑1: Intrathecal Pump Regions Covered, Global (1 of 2) |
| Figure 15‑2: Intrathecal Pump Regions Covered, Global (2 of 2) |
| Figure 15‑3: Total Intrathecal Pump Procedures, Global, 2019 – 2029 |
| Figure 15‑4: Intrathecal Pump Procedures by Region, Global, 2019 – 2029 |
| Figure 15‑5: Intrathecal Pump Procedures by Country, North America, 2019 – 2029 |
| Figure 15‑6: Intrathecal Pump Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 15‑7: Intrathecal Pump Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 15‑8: Intrathecal Pump Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 15‑9: Intrathecal Pump Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 15‑10: Intrathecal Pump Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 15‑11: Intrathecal Pump Procedures by Country, Middle East, 2019 – 2029 |
| Figure 15‑12: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 15‑13: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 15‑14: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 15‑15: Intrathecal Pump Procedures by Country, Africa, 2019 – 2029 |
| Figure 15‑16: Intrathecal Pump Market, Global, 2019 – 2029 |
| Figure 15‑17: Units Sold by Region, Intrathecal Pump Market, Global, 2019 – 2029 |
| Figure 15‑18: Average Selling Price by Region, Intrathecal Pump Market, Global, 2019 – 2029 (US$) |
| Figure 15‑19: Market Value by Region, Intrathecal Pump Market, Global, 2019 – 2029 (US$M) |
| Figure 15‑20: Leading Competitors, Intrathecal Pump Market, Global, 2022 |
| Figure 16‑1: Stereotactic Regions Covered, Global (1 of 2) |
| Figure 16‑2: Stereotactic Regions Covered, Global (2 of 2) |
| Figure 16‑3: Stereotactic Market, Global, 2019 – 2029 |
| Figure 16‑4: Units Sold by Region, Stereotactic Market, Global, 2019 – 2029 |
| Figure 16‑5: Average Selling Price by Region, Stereotactic Market, Global, 2019 – 2029 (US$) |
| Figure 16‑6: Market Value by Region, Stereotactic Market, Global, 2019 – 2029 (US$M) |
| Figure 16‑7: Leading Competitors, Stereotactic Market, Global, 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Neurological Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Neuromodulation Devices, Detachable Coils, Liquid Embolics, and 8 more
$9,995 – $13,995
The full report suite on the global neurological device market includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, neurovascular thrombectomy management, neuromodulation devices, intrathecal pumps and stereotactic devices.
- 2023
- 10 Years
- Global
- 03/21/2023
- 648
- MedSuite
Related Reports
